This is likely to be the case as the observation that a significant proportion of ACC bear nuclear β-catenin staining not explained by CTNNB1 mutation status preceded the discovery of ZNRF3 mutations in ACC [15]. This evidence concerns the gene CTNNB1 and adrenal cortex carcinoma.